SCHEMBL5577939

SCHEMBL5577939

NC(=O)c1nc2[nH]nc(-n3cnnc3-c3ccccc3Cl)c2s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.36
PIK3CA P42336 2/20 0.35
JAK2 O60674 1/20 0.34
ALDH1A1 P00352 5/20 0.33
LMNA P02545 2/20 0.33
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
RAB9A P51151 1/20 0.33
IKBKB O14920 2/20 0.32
PARP1 P09874 1/20 0.32
CSNK2A2 P19784 1/20 0.32
KDR P35968 1/20 0.32
PLK1 P53350 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
HSD17B10 Q99714 2/20 0.32
KDM4E B2RXH2 2/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577941 0.84 HSD11B1 (0.40) HSD11B1PIK3CAJAK2ALDH1A1LMNA
SCHEMBL5577959 0.82 JAK2 (0.35) HSD11B1JAK2ALDH1A1NPC1SMN1; SMN2
SCHEMBL5577960 0.82 GPBAR1 (0.36) JAK2IKBKBPARP1CSNK2A2KDR
SCHEMBL14454989 0.81 MEN1 (0.44) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL14473199 0.69 MEN1 (0.38) ALDH1A1NPC1SMN1; SMN2RAB9AHSD17B10
SCHEMBL5577940 0.67 ALDH1A1 (0.37) HSD11B1PIK3CAALDH1A1LMNANPC1
SCHEMBL3501617 0.66 GRM2 (0.38) ALDH1A1LMNANPC1RAB9AHSD17B10
SCHEMBL4753950 0.66 CA1 (0.41) ALDH1A1LMNANPC1SMN1; SMN2RAB9A
SCHEMBL5577957 0.65 LIMK1 (0.44) ALDH1A1LMNANPC1SMN1; SMN2RAB9A
SCHEMBL5577966 0.65 HSD11B1 (0.35) HSD11B1JAK2ALDH1A1NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators MAP4K2, MAP4K5, MAP4K3 HSD11B1 3411/4885PIK3CA 211/4885JAK2 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.